DatasetName,EIF3CL_S(11) EIF3CL_S(178) EIF3CL_S(181) EIF3CL_S(182) EIF3CL_S(909) EIF3CL_T(263) EIF3CL_T(524),EIF3CL_S(166) EIF3CL_S(18) EIF3CL_S(39) EIF3CL_S(6) EIF3CL_S(732) EIF3CL_T(514),EIF3CL_S(151) EIF3CL_S(156) EIF3CL_S(4),EIF3CL_S(907)
RM2024_Intensity D4-1___3,,,,
RB2022_4_PostEndurance,,0.5204120848455464,,
FSO2013_Ratio M/L normalized Rep3,0.3917801414286552,0.5191184276216826,,
SR2019_MCF7_Biol_repl_3,,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,,
SR2019_LM2_Biol_repl_1,,,,
RCJD2014_15min_1,,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,,
CK2022_7 16-1,,,,
NJH2025_Sub12_HIIT_Mid,,,,
AH2018_LFQ_IT_1_C,,,,
RKK2015_TNF-α/basal,,,,
JJ2018_Ratio H/M normalized pP2,,,,
NJH2025_Sub12_MICT_Pre,,,,
NJH2025_Sub7_MICT_Post,,,,
DL2023_control-3,,,,
ZX2022_Control Replicate 2,0.43812961930498456,0.5291217626645747,,
HS2024_6_B_T3,,,,
JW2015_Intensity pre1,,,,
IMM2018_normalised rep. int. Empty-3,,,,
AMK2021_30R_p5,,,,
FSO2013_Ratio M/L normalized Rep1,0.5131039435905954,0.5569267646019626,,
SR2019_MDAMB231_Biol_repl_4,,,,
GF2025_P2_Sph,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,,
NJH2025_Sub13_HIIT_Mid,,,,
CP2009_Ratio M/L,,,,
NJH2025_Sub7_HIIT_Post,,,,
KBE2022_Log2_Ex_44_T,,,,
DB2022_Intensity L2,,,,
TM2022_mock.4h.C,,,,
AST2020_anti-CD3.2,,0.5192909613722527,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,,
HS2024_7_B_N1,,,,
FSO2013_Ratio M/L normalized Rep1___1,0.4352228413978606,0.5344131095087435,,
SAS2015_AZD/DMSO_Exp3,,,,
RM2024_Intensity D0-2___3,,,,
RM2024_Intensity D6-1,,,,
RB2022_8_RecoverySprint,,0.500033599809777,,
RB2022_5_PreEndurance,,0.5164451264694097,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,,
EP2017_Untreated R#4 normalized log2 ratio,,0.5348247712434708,0.6930080862398887,
WZ2023_Pu_010_30min,,,,
AS2011_Ratio H/L Proteins RNAi_2,,,,
RB2022_4_PreStrength,,0.5318896125007997,,
NJH2024_Sub4_MICT_Post,,,,
AH2018_LFQ_M_1_X,,,,
RB2022_8_RecoveryEndurance,,0.528024025885604,,
KBE2022_Log2_Ex_14_U,,,,
FSO2013_Ratio M/L normalized Rep3___3,0.36186214840701164,0.4830234920965704,,
AH2018_TMTMS3_1_C,,,,
JJ2018_Ratio H/L normalized___1,,,,
ZQ2022_C2,,,,
RB2022_5_PreSprint,,0.5318626347873684,,
PG2020_Intensity 8h_C,,,,
AH2018_SILAC_MR_2_N,,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,,
TM2022_S2.8h.B,,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,0.5288307106712944,,
RM2024_Intensity D6-1___2,,,,
NJH2025_Sub7_MICT_Mid,,,,
LY2019_P1+,,,,
AS2011_Ratio H/L Proteins Inhi_2,,,,
BS2014_Log2(Ratio H/L normalized),,,,
UK2020_HCM_2,,,,
FSO2013_Ratio H/L normalized Rep2___2,,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5012134628191923,0.5713050143632382,
RM2024_Intensity D4-3___3,,,,
RB2022_5_PreStrength,,0.5239555800441947,,
NJH2024_Sub4_MICT_Mid,,,,
TM2022_S2.4h.A,,,,
RB2022_5_PostStrength,,0.5280577573456067,,
GF2025_P6_Sph,,,,
RB2022_2_PreSprint,,0.5261700086312798,,
ZX2022_CB treated Replicate 3,0.4372567061323482,0.5292721849464147,,
RM2024_Intensity D6-2___3,,,,
WZ2023_Pe_025_10min,,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,,
AST2020_anti-CD3+PDL2.1,,0.5207970103505047,,
KBE2022_Log2_Ex_34_U,,,,
WZ2023_Pu_005_10min,,,,
AS2011_Ratio H/L RNAi_2_1,,,,
NJH2024_Sub9_HIIT_Mid,,,,
CK2022_9 40-1,,,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,,
LG2023_GSK3α-1_intensity,,,,
WZ2023_Pu_025_30min,,,,
AH2018_SILAC_MR_2_X,,,,
HS2024_4_PD_T2,,,,
NJH2024_Sub4_HIIT_Pre,,,,
RB2022_2_RecoverySprint,,0.505110332642796,,
AS2011_Ratio H/L Protein RNAi_1,,,,
RM2024_Intensity D2-1___2,,,,
CR2017_Ratio Replicate 1.4,,,,
FR2021_Norm.Intensity.B,,,,
RM2024_Intensity D6-2___1,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,,
RB2022_5_PostSprint,,0.5192794799521683,,
EJN2021_3_Rest_Basal,,,0.6888052240335458,
CR2017_Ratio Replicate 1.3,,,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,,
KTGR2014_Ratio-Rapa 7 mins,,,,
AMK2021_120R_p1,,,,
AH2018_SILAC_3_X,,,,
JJ2018_Ratio M/L normalized pP3,,,,
AH2018_SILAC_M_2_N,,,,
HS2024_7_PD_T2,,,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5243753766913384,,
AH2018_LFQ_1_C,,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,,
KBE2022_Log2_Ex_28_T,,,,
HS2024_3_B_N1,,,,
RM2024_Intensity D4-2___3,,,,
WZ2023_Pe_025_30min,,,,
CK2022_11 40-1,,,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,,
AH2018_SILAC_2_X,,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,,
AS2011_Ratio H/L RNAi_1_2,,,,
KS2014_Intensity E15_1,,,,
FSO2013_Ratio H/L normalized Rep2,,0.5350817789210969,,
WZ2023_Pu_005_20min,,,,
NJH2024_Sub10_MICT_Post,,,,
RM2024_Intensity D2-3___1,,,,
CR2017_Ratio Replicate 1.5,,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,,
HS2024_7_B_T3,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,,
AS2011_Ratio H/L RNAi_1,,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,,
AH2018_LFQ_M_1_C,,,,
NJH2025_Sub7_MICT_Pre,,,,
SR2019_SKBR3_Biol_repl_2,,,,
HS2024_9_B_T2,,,,
KTGR2014_Ratio-AA 7 mins,,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,,
HS2024_3_PD_T1,,,,
FSO2013_Ratio M/L normalized Rep3___2,,,,
SR2019_BT549_Biol_repl_3,,,,
RCJD2014_20min_mean,,,,
FR2021_Norm.Intensity.H,,,,
RB2022_2_PreStrength,,0.528765364131769,,
DB2022_LFQ intensity L1.2,,,,
HS2024_4_B_N1,,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,,
CK2022_1 16-1,,,,
CK2022_1 200-1,,,,
PG2020_Intensity Mock_10h_D,,,,
SR2019_MCF10A_Biol_repl_2,,,,
JJ2018_Ratio M/L normalized pP2___2,,,,
HS2024_6_PD_T1,,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,,
RB2022_6_RecoveryEndurance,,0.5220843577283347,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.5099685038694605,0.6053297282612798,
RCJD2014_5min_1,,,,
RM2024_Intensity D4-1___1,,,,
DL2023_24h-1,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,,
TM2022_S2.4h.C,,,,
SAS2015_PLX/AZD_Exp2,,,,
CR2017_Ratio Replicate 3.3,,,,
PG2020_Intensity 2h_C,,,,
VOI2024_Veh2 di,,,,
ZX2022_CB treated Replicate 2,0.43623060084640225,0.5274066502387941,,
KBE2022_Log2_Ex_8_T,,,,
NJH2025_Sub10_MICT_Post,,,,
HS2024_6_I_T3,,,,
RN2012_L11,0.42756466805288745,0.5218532427373149,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,,
IMM2018_normalised rep. int. Empty-1,,,,
HS2024_5_PD_T1,,,,
AH2018_LFQ_M_2_C,,,,
CK2022_3 40-1,,,,
RBK2021_1260T Early,,,,
NJH2024_Sub4_HIIT_Post,,,,
HS2024_4_I_T1,,,,
YA2020_Reporter_intensity_Cancer_No.5,,,,
HH2022_Reporter intensity 8,,,,
ZQ2022_N2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,,
FSO2013_Ratio H/L normalized Rep3___3,,,,
AH2018_TMTMS3_2_N,,,,
EJN2021_5_Rest_Basal,,,0.6876269022119551,
NJH2025_Sub2_HIIT_Post,,,,
NJH2025_Sub1_MICT_Post,,,,
HS2024_9_B_T1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,,
JAW2011_Ratio H/L LS2_1,,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,,
NJH2024_Sub6_HIIT_Pre,,,,
AH2018_SILAC_3_N,,,,
YA2020_Reporter_intensity_Normal_No.1,,,,
HS2024_3_B_T1,,,,
JJ2018_Ratio H/L normalized___2,,,,
RM2024_Intensity D0-2,,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,,
RB2022_7_PostStrength,,0.5180666004008344,,
RB2022_1_PostEndurance,,0.4815217992180217,,
CR2017_Ratio Replicate 3,,,,
SR2019_Hs578T_Biol_repl_3,,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,,
RBK2021_1244T Early,,,,
RB2022_3_PostSprint,,0.5121514762100496,,
NJH2024_Sub13_MICT_Mid,,,,
KTGR2014_Ratio-AA 2 mins,,,,
GF2025_P7_Sph,,,,
HS2024_8_I_T3,,,,
CF2017_EOC 3,,,0.6600021519998888,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,,
HS2024_6_PD_T3,,,,
DL2023_12h-2,,,,
RM2024_Intensity D6-3___1,,,,
FS2019_Ctr1,,,,
WZ2023_Pu_010_20min,,,,
AS2011_Ratio H/L_3,,,,
CK2022_1 40-1,,,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,0.5117836294336763,,
CK2022_8 16-1,,,,
KS2014_Intensity N3,,,,
RB2022_4_RecoveryEndurance,,0.5295481413844916,,
RB2022_5_RecoveryEndurance,,0.5262566833635174,,
JAW2011_Ratio H/L LS1a_2,,,,
NJH2024_Sub12_HIIT_Mid,,,,
AH2018_LFQ_IT_1_N,,,,
FSO2013_Ratio H/M normalized Rep2,,0.5052953876039213,,
RAM2015_Log2 A,,0.548939256164092,,
HS2024_8_PD_T1,,,,
JJ2018_Ratio H/L normalized pP2,,,,
CF2017_OSE 27,,,0.6406653312504534,
KS2014_Intensity E15_2,,,,
BS2014_Log2(Ratio H/L protein),,,,
PG2020_Intensity 8h_A,,,,
HS2024_7_I_T1,,,,
VOI2024_Veh3 di,,,,
RKK2015_TNF-α+SC-514/basal,,,,
SR2019_JIMT1_Biol_repl_1,,,,
HW2015_Ratio H/L normalized Exp2,,,,
HS2024_3_I_N1,,,,
AH2018_SILAC_M_3_X,,,,
NJH2024_Sub9_HIIT_Post,,,,
AS2011_Ratio H/L RNAi_1_3,,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,,
NJH2025_Sub1_HIIT_Pre,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,,
NJH2024_Sub4_HIIT_Mid,,,,
VOI2024_0.1uM 2 h_1 di,,,,
KBE2022_Log2_Ex_6_T,,,,
RM2024_Intensity D4-3___1,,,,
AH2018_LFQ_4_X,,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,,
RB2022_8_PostEndurance,,0.5231721353800468,,
NJH2025_Sub4_MICT_Mid,,,,
YP2020_Intensity C30_R1_mult_log2,,,,
AST2020_anti-CD3.1,,0.518569787367091,,
NJH2025_Sub4_HIIT_Post,,,,
EP2017_Untreated R#4 log2 ratio,,0.5348267307768424,0.6926172131603373,
HS2024_6_B_N1,,,,
KBE2022_Log2_Ex_27_T,,,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,,
VOI2024_0.1uM 24 h_1 mono,,,,
AMK2021_120R_p5,,,,
AS2011_Ratio H/L Proteins,,,,
NJH2024_Sub7_HIIT_Post,,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.518337154853873,0.6308489658028807,
AS2011_Ratio H/L RNAi_2_2,,,,
RB2022_7_RecoveryStrength,,0.5208151927820125,,
AH2018_SILAC_IT_3_X,,,,
JAW2011_Ratio H/L,,,,
PG2020_Intensity 10h_C,,,,
FSO2013_Ratio M/L normalized Rep2,0.4272140492889816,0.5502198903378257,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,,
HH2022_Reporter intensity 5,,,,
SR2019_HCC1954_Biol_repl_2,,,,
CK2022_14 40-1,,,,
RB2022_6_PreSprint,,0.531218398809997,,
NJH2025_Sub12_MICT_Mid,,,,
PG2020_Intensity 4h_D,,,,
NJH2025_Sub2_MICT_Post,,,,
AH2018_LFQ_4_C,,,,
DL2023_control-1,,,,
AR2021_ALG 10 μM,,,,
JAW2011_Ratio H/L LS2_2,,,,
AH2018_SILAC_IT_3_N,,,,
EJN2021_4_Rest_Ins,,,0.6907678066817605,
RN2012_H05,0.44782902047282025,0.5173274012401022,,
NJH2024_Sub7_HIIT_Mid,,,,
GF2025_P2_Adh,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,,
RB2022_8_PostSprint,,0.5185629280124838,,
EJN2021_1_Rest_Ins,,,0.6901920349320583,
HH2022_Reporter intensity 3,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,,
AH2018_SILAC_IT_1_C,,,,
JW2021_After_3,,0.5255914026171603,,
GF2025_P8_Sph,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,,
JJ2018_Ratio M/L normalized pP2___1,,,,
AH2018_SILAC_2_N,,,,
CK2022_11 200-1,,,,
CK2022_12 200-1,,,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,,
RM2024_Intensity D2-1___3,,,,
NJH2024_Sub1_MICT_Pre,,,,
HH2022_Reporter intensity 9,,,,
WZ2023_Su_010_20min,,,,
AH2018_TMTMS2_2_N,,,,
NJH2024_Sub13_MICT_Pre,,,,
KBE2022_Log2_Ex_41_U,,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.508467123196166,0.6419860312798907,
AH2018_TMTMS3_Pool,,,,
KS2014_Intensity N4,,,,
NJH2024_Sub1_HIIT_Post,,,,
MM2018_Ratio H/L replicate2,,,,
RM2024_Intensity D4-2___2,,,,
NJH2024_Sub13_HIIT_Pre,,,,
CF2017_OSE 26,,0.5349136966277154,0.6593073334697065,
CK2022_14 200-1,,,,
SR2019_Hs578T_Biol_repl_1,,,,
RB2022_7_PostSprint,,0.5207198380611472,,
TM2022_mock.4h.A,,,,
NJH2025_Sub12_HIIT_Pre,,,,
AH2018_TMTMS3_1_N,,,,
AST2020_anti-CD3+PDL2.2,,0.5210683072078789,,
PG2020_Intensity Mock_10h_A,,,,
JW2021_After_2,,0.5345634760369811,,
NJH2024_Sub2_MICT_Post,,,,
EJN2021_2_Rest_Ins,,,0.6844649549483534,
SR2019_LM2_Biol_repl_4,,,,
CP2009_Ratio H/M,,,,
JAW2011_Ratio H/L HS,,,,
CK2022_13 16-1,,,,
GF2025_P1_Adh,,,,
GF2025_P1_Sph,,,,
EJN2021_5_Ex_Basal,,,0.6889796916796032,
HS2024_7_I_T3,,,,
JJ2018_Ratio H/L normalized pP2___2,,,,
WZ2023_Pe_010_10min,,,,
CF2017_EOC 1,,,0.656475602629745,
CK2022_3 200-1,,,,
AH2018_LFQ_IT_3_C,,,,
SR2019_Hs578T_Biol_repl_2,,,,
NJH2024_Sub12_HIIT_Post,,,,
JJ2018_Ratio H/L normalized pP1___2,,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,,
NJH2024_Sub10_MICT_Mid,,,,
NJH2024_Sub13_MICT_Post,,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,,
RB2022_3_RecoverySprint,,0.494138817585645,,
NJH2025_Sub1_HIIT_Mid,,,,
RCJD2014_20min_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,,
HS2024_6_PD_T2,,,,
HS2024_5_B_T1,,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,,
DL2023_12h-3,,,,
SR2019_MDAMB231_Biol_repl_2,,,,
HS2024_3_B_T2,,,,
RB2022_6_PreStrength,,0.5217589179101344,,
CK2022_2 40-1,,,,
RB2022_1_PostSprint,,0.5205578661576794,,
CK2022_4 200-1,,,,
JW2021_Before_2,,0.5104640585344417,,
TM2022_S2.12h.A,,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,,
CK2022_5 16-1,,,,
AR2021_ALG 1 μM,,,,
HS2024_4_B_T1,,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,,
SR2019_BT549_Biol_repl_4,,,,
EJN2021_1_Rest_Basal,,,0.6863639312928896,
NJH2025_Sub8_MICT_Post,,,,
RCJD2014_5min_3,,,,
CR2017_Ratio Replicate 3.2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,,
GF2025_P7_Adh,,,,
CK2022_9 16-1,,,,
NJH2024_Sub6_HIIT_Post,,,,
AMK2021_30R_p3,,,,
AS2011_Ratio H/L Normalized RNAi_2,,,,
RM2024_Intensity D0-2___2,,,,
KS2014_Intensity pY_N4,,,,
CK2022_13 200-1,,,,
AS2011_Ratio H/L Normalized_2,,,,
PG2020_Intensity 6h_D,,,,
CK2022_16 16-1,,,,
FS2019_db/db3,,,,
CK2022_15 40-1,,,,
NJH2024_Sub9_MICT_Pre,,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,,
WZ2023_Su_005_10min,,,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,,
KBE2022_Log2_Ex_41_T,,,,
AMK2021_Ctrl_p1,,,,
AH2018_LFQ_IT_3_X,,,,
HS2024_5_PD_T3,,,,
AH2018_TMTMS3_3_X,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,,
KBE2022_Log2_Ex_40_U,,,,
AH2018_LFQ_M_1_N,,,,
KBE2022_Log2_Ex_27_U,,,,
HW2015_Ratio M/L normalized Exp3,,,,
RKK2015_TNF-α/IKKb(K44M),,,,
AH2018_SILAC_M_1_N,,,,
HW2015_Ratio M/L normalized Exp1,,,,
RB2022_5_RecoveryStrength,,0.5137962733434557,,
YP2020_Intensity P10_R1_mult_log2,,,,
RB2022_7_PreStrength,,0.524727142111202,,
YA2020_Reporter_intensity_Normal_No.4,,,,
NJH2025_Sub13_HIIT_Pre,,,,
PG2020_Intensity CT_D,,,,
NJH2025_Sub9_MICT_Post,,,,
VOI2024_Veh1 mono,,,,
CK2022_12 16-1,,,,
RN2012_L13,0.456399576231797,0.5397213654880103,,
LG2023_Control-1_intensity,,,,
RM2024_Intensity D6-3___2,,,,
KBE2022_Log2_Ex_8_U,,,,
SR2019_SKBR3_Biol_repl_3,,,,
NJH2024_Sub1_MICT_Post,,,,
HS2024_3_I_T2,,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,,
RM2024_Intensity D0-3___3,,,,
HS2024_6_I_T2,,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,,
AS2011_Ratio H/L Protein Inhi_1,,,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5081452962765511,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,,
CK2022_10 40-1,,,,
NJH2024_Sub12_HIIT_Pre,,,,
NJH2024_Sub8_MICT_Pre,,,,
RM2024_Intensity D0-1___1,,,,
LY2019_P3+,,,,
HH2022_Reporter intensity 6,,,,
RB2022_2_RecoveryStrength,,0.5266128240882871,,
KTGR2014_Ratio-AA 15 mins,,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,,
KS2014_Intensity pY_N3,,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,,
LY2019_P5-,,,,
HW2015_Ratio M/L normalized Exp2,,,,
SR2019_HCC1419_Biol_repl_1,,,,
AH2018_TMTMS2_3_X,,,,
GF2025_P3_Adh,,,,
SR2019_JIMT1_Biol_repl_2,,,,
AH2018_TMTMS2_1_C,,,,
RM2024_Intensity D0-1___2,,,,
LY2019_P4+,,,,
KBE2022_Log2_Ex_19_U,,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,,
RB2022_4_PostStrength,,0.5202943361296514,,
LG2023_GSK3α-3_intensity,,,,
YA2020_Reporter_intensity_Cancer_No.1,,,,
AST2020_Control,,0.5202999646782975,,
JAW2011_Ratio H/L LS1a,,,,
RCJD2014_5min_mean,,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,0.5152888084994027,,
NJH2025_Sub1_MICT_Mid,,,,
TM2022_S2.12h.C,,,,
NJH2025_Sub9_MICT_Mid,,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,,
FSO2013_Ratio M/L normalized Rep2___1,0.43323053666901534,0.5602050228878437,,
LG2023_Control-2_intensity,,,,
NJH2024_Sub8_HIIT_Pre,,,,
KS2014_Intensity pY_N2,,,,
RB2022_5_RecoverySprint,,0.518465028283066,,
RB2022_7_RecoverySprint,,0.5219426261305267,,
YA2020_Reporter_intensity_Normal_No.3,,,,
HS2024_8_B_T2,,,,
AH2018_LFQ_1_X,,,,
RM2024_Intensity D6-1___1,,,,
RCJD2014_10min_2,,,,
FR2021_Norm.Intensity.M,,,,
RM2024_Intensity D0-3___1,,,,
KS2014_Intensity N2,,,,
HH2022_Reporter intensity 1,,,,
HH2022_Reporter intensity 2,,,,
RM2024_Intensity D6-2___2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,,
RM2024_Intensity D2-3___2,,,,
YA2020_Reporter_intensity_Normal_No.5,,,,
SR2019_MCF7_Biol_repl_1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,,
HS2024_8_B_T1,,,,
NJH2025_Sub6_HIIT_Pre,,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,0.5150808558438943,,
EP2017_Untreated R#2 log2 ratio,,0.5338829943050963,0.5760959110582587,
SR2019_LM2_Biol_repl_3,,,,
RB2022_4_RecoveryStrength,,0.5158550749864265,,
CR2017_Ratio Replicate 2,,,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,,
FSO2013_Ratio H/M normalized Rep3,,0.519956355529957,,
AR2021_KD 72h,,,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,,
KBE2022_Log2_Ex_18_U,,,,
AS2011_Ratio H/L Inhi_1_1,,,,
NJH2024_Sub8_MICT_Post,,,,
AH2018_TMTMS3_3_C,,,,
KBE2022_Log2_Ex_9_U,,,,
AH2018_SILAC_M_3_N,,,,
KBE2022_Log2_Ex_13_T,,,,
RM2024_Intensity D0-3,,,,
SR2019_SKBR3_Biol_repl_1,,,,
PG2020_Intensity Mock_10h_C,,,,
CF2017_OSE 29,,0.5247454157765871,0.6163408486618475,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,,
NJH2025_Sub1_HIIT_Post,,,,
DL2023_24h-2,,,,
HS2024_7_B_N2,,,,
PG2020_Intensity 10h_A,,,,
RN2012_L12,0.4213647262281675,0.5168644162818028,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,,
NJH2024_Sub8_MICT_Mid,,,,
AH2018_LFQ_IT_4_C,,,,
SAS2015_PLX/AZD_Exp1,,,,
FR2021_Norm.Intensity.A,,,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5122068751145691,,
JW2015_Intensity cap2,,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,,
NJH2024_Sub6_MICT_Post,,,,
CK2022_8 40-1,,,,
RB2022_7_RecoveryEndurance,,0.5280299210651588,,
NJH2025_Sub12_HIIT_Post,,,,
EJN2021_4_Ex_Basal,,,0.6917526064293869,
TM2022_S2.12h.B,,,,
RN2012_L15,0.44039155616800507,0.48880938367305254,,
KS2014_Intensity pY_PV3,,,,
TM2022_S2.4h.B,,,,
PG2020_Intensity 4h_A,,,,
FSO2013_Ratio H/M normalized Rep2___2,,,,
TM2022_mock.4h.B,,,,
KBE2022_Log2_Ex_24_U,,,,
NJH2025_Sub13_MICT_Mid,,,,
KS2014_Intensity C3,,,,
RB2022_1_PreSprint,,0.5264617804383139,,
HS2024_4_I_N1,,,,
CK2022_7 200-1,,,,
CK2022_5 200-1,,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5354680265100286,,
NJH2024_Sub10_HIIT_Mid,,,,
RB2022_2_PostEndurance,,0.5190900217790588,,
AH2018_LFQ_2_C,,,,
AH2018_SILAC_MR_1_X,,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,,
IMM2018_normalised rep. int. Empty-2,,,,
RM2024_Intensity D4-1,,,,
KBE2022_Log2_Ex_25_U,,,,
AH2018_SILAC_3_C,,,,
EJN2021_5_Rest_Ins,,,0.6904134157546088,
VOI2024_0.1uM 24 h_3 di,,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,0.5182849023555857,,
DB2022_LFQ intensity L2.1,,,,
FSO2013_Ratio H/M normalized Rep1,,0.5099311872505602,,
CK2022_4 16-1,,,,
AS2011_Ratio H/L,,,,
SR2019_MCF7_Biol_repl_4,,,,
EJN2021_2_Ex_Ins,,,0.6896983520250609,
AS2011_Ratio H/L Inhi_2_3,,,,
JAW2011_Ratio H/L LS1a_1,,,,
AH2018_LFQ_1_N,,,,
SAS2015_PLX/DMSO_Exp1,,,,
SFR2015_HL_log2_ratio_avg_c,0.4367331783640777,0.5067577372656268,,
JJ2018_Ratio M/L normalized pP2,,,,
NJH2024_Sub7_MICT_Mid,,,,
PG2020_Intensity 6h_B,,,,
FSO2013_Ratio H/L normalized Rep3,,0.5330210990820714,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,,
JJ2018_Ratio M/L normalized,,,,
KTGR2014_Ratio-AA 30 mins,,,,
JW2021_After_1,,0.5286012158152947,,
NJH2025_Sub2_MICT_Mid,,,,
HS2024_6_B_N2,,,,
KBE2022_Log2_Ex_9_T,,,,
AH2018_SILAC_IT_2_N,,,,
AH2018_SILAC_IT_1_X,,,,
HW2015_Ratio H/L normalized Exp3,,,,
HS2024_7_PD_T1,,,,
UK2020_UA_2,,,,
RM2024_Intensity D2-1___1,,,,
GF2025_P10_Sph,,,,
WZ2023_Pe_025_20min,,,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,,
AH2018_LFQ_2_N,,,,
HS2024_4_I_N2,,,,
AH2018_TMTMS2_3_N,,,,
RN2012_H06,0.4392979394129312,0.48240697296427504,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,,
HS2024_4_PD_T3,,,,
WZ2023_Su_005_30min,,,,
SR2019_HCC1419_Biol_repl_4,,,,
JJ2018_Ratio H/M normalized___2,,,,
SR2019_JIMT1_Biol_repl_3,,,,
AS2011_Ratio H/L Protein,,,,
UK2020_HCM_3,,,,
NJH2024_Sub10_HIIT_Post,,,,
CR2017_Ratio Replicate 3.1,,,,
WZ2023_Su_025_10min,,,,
AH2018_LFQ_IT_4_X,,,,
CP2009_Ratio H/L,,,,
VOI2024_0.1uM 24 h_3 mono,,,,
RB2022_4_RecoverySprint,,0.5128991235018896,,
RM2024_Intensity D6-3,,,,
WZ2023_Su_005_20min,,,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,,
SFR2015_HL_log2_ratio_avg_a,,0.5066941834839747,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,,
RB2022_1_PreEndurance,,0.5273710201671531,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,,
LG2023_GSK3α-2_intensity,,,,
EP2017_Pervanadate R#1 log2 ratio,,0.5065224563104849,0.6089319372549035,
NJH2025_Sub6_HIIT_Post,,,,
RB2022_6_RecoverySprint,,0.517707981291302,,
KS2014_Intensity,,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,,
PG2020_Intensity 8h_D,,,,
LY2019_P7+,,,,
EP2017_Untreated R#1 normalized log2 ratio,,0.5012212657357389,0.5614026546585557,
RN2012_L10,0.4357544966054277,0.5368110175930147,,
PG2020_Intensity 4h_C,,,,
EP2017_Mitotic R#3 normalized log2 ratio,,0.5094709407333476,0.5484833716174613,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,,
DB2022_LFQ intensity L1,,,,
KBE2022_Log2_Ex_24_T,,,,
RB2022_8_PostStrength,,0.520363308020992,,
AH2018_SILAC_IT_2_X,,,,
HS2024_4_B_T3,,,,
NJH2024_Sub2_HIIT_Post,,,,
HS2024_8_B_N2,,,,
NJH2025_Sub8_HIIT_Pre,,,,
JJ2018_Ratio H/L normalized pP2___1,,,,
HS2024_8_I_T2,,,,
KBE2022_Log2_Ex_6_U,,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,,
CR2017_Ratio Replicate 1.1,,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,,
CK2022_16 200-1,,,,
VOI2024_0.1uM 2 h_3 di,,,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.51095396235849,0.5908804536710506,
GF2025_P9_Sph,,,,
CK2022_6 200-1,,,,
NJH2024_Sub7_MICT_Post,,,,
AH2018_TMTMS3_2_X,,,,
NJH2024_Sub8_HIIT_Post,,,,
DB2022_LFQ intensity R1,,,,
JW2015_Intensity cap3,,,,
SR2019_HCC1954_Biol_repl_1,,,,
HS2024_4_I_T2,,,,
NJH2024_Sub2_MICT_Mid,,,,
VOI2024_0.1uM 2 h_2 mono,,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,,
HS2024_4_PD_T1,,,,
SAS2015_AZD/DMSO_Exp1,,,,
NJH2024_Sub1_MICT_Mid,,,,
IMM2018_normalised rep. int. CDK5L-3,,,,
HS2024_3_B_T3,,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,,
NJH2025_Sub13_MICT_Pre,,,,
SR2019_MDAMB231_Biol_repl_3,,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,,
MM2018_Ratio H/L replicate1,,,,
PG2020_Intensity 2h_D,,,,
EP2017_Untreated R#3 normalized log2 ratio,,0.5240221885766972,0.6142726978989472,
MV2014_Ratio M/H normalized A3___3 (10 min),,,,
NJH2024_Sub7_HIIT_Pre,,,,
JAW2011_Ratio H/L LS2,,,,
CK2022_8 200-1,,,,
KS2014_Intensity pY_C4,,,,
CR2017_Ratio Replicate 3.5,,,,
RB2022_7_PostEndurance,,0.5145267304913225,,
NJH2025_Sub4_HIIT_Pre,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,,
TM2022_mock.12h.A,,,,
JJ2018_Ratio H/L normalized pP1,,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5105986502919001,0.5886186819777927,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,,
KS2014_Intensity pY_E5_4,,,,
RM2024_Intensity D4-3___2,,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,,
AH2018_SILAC_2_C,,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,,
HS2024_7_I_N1,,,,
KBE2022_Log2_Ex_29_T,,,,
HS2024_7_I_T2,,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,,
HS2024_6_B_T2,,,,
AMK2021_45I_p5,,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,,
SAS2015_PLX/DMSO_Exp2,,,,
EJN2021_1_Ex_Basal,,,0.6948711787699026,
FR2021_Intensity.M,,,,
RB2022_2_PostSprint,,0.5188128763247972,,
AH2018_SILAC_MR_3_N,,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,,
CF2017_FTE 13,,0.52022856143231,0.6120226434294477,
PG2020_Intensity CT_C,,,,
ZCP2016_Ratio H/L Rep 1,,,,
FS2019_db/db2,,,,
KS2014_Intensity pY_PV4,,,,
KBE2022_Log2_Ex_39_U,,,,
EP2017_Untreated R#3 log2 ratio,,0.5237962208315622,0.6140578771743687,
RB2022_2_PostStrength,,0.5247119811067857,,
AS2011_Ratio H/L Normalized_1,,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,,
CR2017_Ratio Replicate 3.4,,,,
HS2024_8_PD_T2,,,,
FS2019_Ctr2,,,,
RB2022_6_PreEndurance,,0.5194848555421024,,
FR2021_Norm.Intensity.G,,,,
NJH2025_Sub9_HIIT_Post,,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,,
RM2024_Intensity D4-3,,,,
HS2024_8_B_N1,,,,
NJH2025_Sub10_MICT_Mid,,,,
KBE2022_Log2_Ex_15_U,,,,
AS2011_Ratio H/L Normalized Inhi_2,,,,
RKK2015_TNF-α/SC-514,,,,
RB2022_3_PreSprint,,0.5295059262685968,,
CR2017_Ratio Replicate 2.3,,,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,,
GF2025_P4_Adh,,,,
YA2020_Reporter_intensity_Normal_No.2,,,,
YP2020_Intensity P30_R2_mult_log2,,,,
NJH2025_Sub13_MICT_Post,,,,
HS2024_4_B_N2,,,,
HS2024_3_PD_T3,,,,
AMK2021_120R_p3,,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,,
NJH2025_Sub10_HIIT_Pre,,,,
FR2021_Intensity.G,,,,
RAM2015_Log2 C,,0.5244956185542987,,
AS2011_Ratio H/L Proteins Inhi_1,,,,
FSO2013_Ratio H/M normalized Rep1___3,,,,
AH2018_LFQ_M_2_N,,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,,
KBE2022_Log2_Ex_40_T,,,,
CK2022_2 16-1,,,,
RAM2015_Log2 B,,0.5143053142463998,,
YP2020_Intensity C10_R1_mult_log2,,,,
FSO2013_Ratio M/L normalized Rep1___2,,,,
NJH2025_Sub8_MICT_Pre,,,,
EJN2021_4_Rest_Basal,,,0.6901665236489937,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,,
JJ2018_Ratio H/M normalized pP3___1,,,,
VOI2024_Veh2 mono,,,,
HS2024_6_B_T1,,,,
UK2020_HCM_5,,,,
NJH2025_Sub10_HIIT_Post,,,,
VOI2024_0.1uM 2 h_3 mono,,,,
JW2015_Intensity pre3,,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,,
DL2023_24h-3,,,,
HS2024_7_PD_T3,,,,
PG2020_Intensity Mock_10h_B,,,,
WZ2023_Su_025_30min,,,,
AH2018_LFQ_4_N,,,,
CR2017_Ratio Replicate 1.2,,,,
AS2011_Ratio H/L Normalized by Proteins,,,,
RB2022_6_RecoveryStrength,,0.5207142017988459,,
HS2024_8_I_N1,,,,
AMK2021_Ctrl_p3,,,,
AS2011_Ratio H/L Protein Inhi_2,,,,
HH2022_Reporter intensity 7,,,,
AH2018_SILAC_M_1_X,,,,
RB2022_7_PreEndurance,,0.5182359179146242,,
VOI2024_0.1uM 24 h_2 di,,,,
DL2023_control-2,,,,
LY2019_P6+,,,,
DB2022_LFQ intensity R2,,,,
GF2025_P6_Adh,,,,
VOI2024_Veh1 di,,,,
AS2011_Ratio H/L RNAi_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,,
VOI2024_Veh3 mono,,,,
HS2024_5_I_T2,,,,
NJH2025_Sub7_HIIT_Mid,,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,,
RB2022_6_PostSprint,,0.5091526163473327,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,,
AS2011_Ratio H/L Inhi_1,,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,,
AH2018_TMTMS3_2_C,,,,
SR2019_Hs578T_Biol_repl_4,,,,
RB2022_8_PreStrength,,0.5248114703073449,,
KS2014_Intensity C5,,,,
RM2024_Intensity D0-1,,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,,
YP2020_Intensity P30_R1_mult_log2,,,,
NJH2025_Sub2_HIIT_Pre,,,,
RB2022_3_RecoveryEndurance,,0.5298172803539556,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,0.5127942551057648,,
GF2025_P9_Adh,,,,
RB2022_3_PostStrength,,0.5160279683543578,,
TM2022_S2.8h.A,,,,
AS2011_Ratio H/L RNAi_1_1,,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,,
NJH2025_Sub2_MICT_Pre,,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,,
HS2024_4_B_T2,,,,
SR2019_BT549_Biol_repl_1,,,,
AH2018_LFQ_M_4_N,,,,
NJH2024_Sub8_HIIT_Mid,,,,
PG2020_Intensity 8h_B,,,,
AH2018_LFQ_2_X,,,,
PG2020_Intensity 2h_B,,,,
AS2011_Ratio H/L Proteins RNAi_1,,,,
RB2022_4_PostSprint,,0.5160706573933881,,
KS2014_Intensity E15_3,,,,
GF2025_P3_Sph,,,,
DB2022_LFQ intensity L2,,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,,
AH2018_SILAC_1_C,,,,
NJH2024_Sub1_HIIT_Pre,,,,
FSO2013_Ratio M/L normalized Rep2___2,,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.5113414228125752,0.6474079748997995,
AS2011_Ratio H/L RNAi_2_3,,,,
AH2018_SILAC_IT_1_N,,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,,
RB2022_4_PreEndurance,,0.5255259611842377,,
JJ2018_Ratio M/L normalized pP1,,,,
CR2017_Ratio Replicate 2.4,,,,
ZQ2022_N1,,,,
LY2019_P6-,,,,
RM2024_Intensity D2-3,,,,
UK2020_HCM_1,,,,
JW2015_Intensity pre2,,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,,
RM2024_Intensity D2-1,,,,
NJH2025_Sub12_MICT_Post,,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,,
RN2012_L14,0.4398468926354407,0.47554358349943743,,
AH2018_LFQ_3_N,,,,
RKK2015_TNF-α/IKKb,,,,
SFR2015_HL_log2_ratio_std_b,0.4260941373840302,0.5185304028994201,,
UK2020_UA_1,,,,
KBE2022_Log2_Ex_13_U,,,,
AS2011_Ratio H/L Normalized Inhi_1,,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,0.5190187714473157,,
RB2022_1_RecoverySprint,,0.5145047500178698,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,,
JJ2018_Ratio H/L normalized pP3,,,,
CK2022_7 40-1,,,,
AS2011_Ratio H/L Inhi_1_3,,,,
NJH2025_Sub10_HIIT_Mid,,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,,
JAW2011_Ratio H/L LS1b_1,,,,
PG2020_Intensity 4h_B,,,,
SR2019_BT549_Biol_repl_2,,,,
RM2024_Intensity D4-2,,,,
DB2022_LFQ intensity R2.2,,,,
JJ2018_Ratio H/L normalized,,,,
RB2022_5_PostEndurance,,0.5078152068359095,,
HS2024_5_PD_T2,,,,
WZ2023_Su_025_20min,,,,
RM2024_Intensity D2-2___1,,,,
IMM2018_normalised rep. int. CDK5L-2,,,,
LY2019_P8-,,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,,
FSO2013_Ratio H/L normalized Rep1,,0.5222852898365385,,
NJH2024_Sub2_HIIT_Pre,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,,
CK2022_13 40-1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,,
RN2012_H02,0.4417288281768833,0.5244291308954431,,
PG2020_Intensity 10h_D,,,,
RB2022_8_PreEndurance,,0.5201031228075917,,
HS2024_3_B_N2,,,,
EJN2021_4_Ex_Ins,,,0.6889819466379802,
AS2011_Ratio H/L Normalized by Protein,,,,
EJN2021_1_Ex_Ins,,,0.6905133552314107,
EP2017_Pervanadate R#3 log2 ratio,,0.5005758280467171,0.5709048000015277,
FSO2013_Ratio M/L normalized Rep1___3,0.5198322367698361,0.5444563042376689,,
NJH2025_Sub4_HIIT_Mid,,,,
RCJD2014_5min_2,,,,
RB2022_6_PostStrength,,0.5293538111655921,,
AH2018_SILAC_MR_3_C,,,,
AH2018_LFQ_M_4_C,,,,
NJH2024_Sub4_MICT_Pre,,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,,
DL2023_12h-1,,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,,
DB2022_LFQ intensity L1.1,,,,
NJH2025_Sub6_MICT_Pre,,,,
NJH2025_Sub6_MICT_Post,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,,
RN2012_H04,0.43586859573935977,0.5326530109532223,,
CK2022_6 40-1,,,,
DB2022_LFQ intensity R2.1,,,,
KBE2022_Log2_Ex_42_U,,,,
LY2019_P3-,,,,
FR2021_Intensity.A,,,,
EJN2021_3_Ex_Ins,,,0.6894171283869589,
MV2014_Ratio M/L normalized A1___1 (2 min),,,,
WZ2023_Pe_005_30min,,,,
HS2024_8_PD_T3,,,,
EJN2021_3_Ex_Basal,,,0.688643546437425,
AST2020_Control.1,,0.5183392855677318,,
JW2015_Intensity cap1,,,,
PG2020_Intensity CT_A,,,,
FS2019_Ctr3,,,,
WZ2023_Pu_025_20min,,,,
NJH2025_Sub4_MICT_Post,,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,,
GF2025_P10_Adh,,,,
RB2022_1_RecoveryStrength,,0.5233345677047545,,
SR2019_HCC1954_Biol_repl_4,,,,
FR2021_Norm.Intensity.N,,,,
HS2024_5_B_N1,,,,
FSO2013_Ratio H/M normalized Rep3___3,,,,
AH2018_TMTMS2_2_C,,,,
RB2022_4_PreSprint,,0.5269259657051739,,
DB2022_Intensity R2,,,,
AH2018_TMTMS2_Pool,,,,
HS2024_8_I_N2,,,,
RB2022_3_RecoveryStrength,,0.5285668655583082,,
NJH2024_Sub6_HIIT_Mid,,,,
AH2018_SILAC_M_1_C,,,,
LY2019_P8+,,,,
RB2022_2_RecoveryEndurance,,0.5227252987101557,,
JJ2018_Ratio H/M normalized pP2___1,,,,
JAW2011_Ratio H/L HS_1,,,,
RB2022_3_PostEndurance,,0.5119555623917013,,
KS2014_Intensity pY_PV1,,,,
JAW2011_Ratio H/L LS1b_2,,,,
SR2019_MCF7_Biol_repl_2,,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.517158905521109,0.6493896623875326,
AS2011_Ratio H/L Normalized RNAi_1_1,,,,
AH2018_LFQ_M_4_X,,,,
NJH2024_Sub6_MICT_Pre,,,,
JJ2018_Ratio M/L normalized pP1___2,,,,
YP2020_Intensity C30_R2_mult_log2,,,,
NJH2024_Sub9_HIIT_Pre,,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,,
RM2024_Intensity D0-1___3,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,,
KBE2022_Log2_Ex_28_U,,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,,
CF2017_FTE 17,,0.519053029150144,0.6646958305457406,
LY2019_P2-,,,,
AH2018_LFQ_IT_1_X,,,,
JJ2018_Ratio H/L normalized pP3___1,,,,
RB2022_8_RecoveryStrength,,0.5115379339124149,,
WZ2023_Pe_005_20min,,,,
AST2020_Control.2,,0.5185010509402689,,
NJH2025_Sub6_MICT_Mid,,,,
RCJD2014_10min_1,,,,
FSO2013_Ratio H/L normalized Rep2___3,,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,,
HS2024_3_I_T1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,,
CK2022_4 40-1,,,,
SR2019_MCF10A_Biol_repl_4,,,,
KS2014_Intensity pY_C5,,,,
NJH2025_Sub4_MICT_Pre,,,,
NJH2024_Sub9_MICT_Post,,,,
CF2017_OSE 28,,,0.6606579452612403,
HS2024_5_B_T2,,,,
HS2024_6_I_T1,,,,
HS2024_5_B_T3,,,,
JJ2018_Ratio H/M normalized pP1___1,,,,
KBE2022_Log2_Ex_36_U,,,,
AH2018_TMTMS3_3_N,,,,
SR2019_HCC1419_Biol_repl_2,,,,
FR2021_Intensity.N,,,,
AS2011_Ratio H/L Inhi_2_1,,,,
AH2018_SILAC_MR_1_C,,,,
NJH2024_Sub1_HIIT_Mid,,,,
NJH2025_Sub8_HIIT_Mid,,,,
EP2017_Mitotic R#3 log2 ratio,,0.5098232416509527,0.5508614296667756,
KBE2022_Log2_Ex_36_T,,,,
NJH2025_Sub6_HIIT_Mid,,,,
WZ2023_Pu_005_30min,,,,
KS2014_Intensity C2,,,,
FSO2013_Ratio H/L normalized Rep1___2,,,,
RM2024_Intensity D2-2,,,,
KBE2022_Log2_Ex_42_T,,,,
CK2022_9 200-1,,,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,,
JJ2018_Ratio H/M normalized pP3___2,,,,
DB2022_LFQ intensity R1.1,,,,
CK2022_10 200-1,,,,
NJH2024_Sub9_MICT_Mid,,,,
JAW2011_Ratio H/L_2,,,,
HS2024_7_I_N2,,,,
RBK2021_1332T Late,,,,
LY2019_P1-,,,,
RKK2015_TNF-α/basal.1,,,,
RKK2015_TNF-α/TNF-α+SC-514,,,,
CR2017_Ratio Replicate 2.5,,,,
HS2024_3_I_T3,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,,
AS2011_Ratio H/L Normalized RNAi_1,,,,
KS2014_Intensity E15_4,,,,
ZQ2022_C3,,,,
EJN2021_3_Rest_Ins,,,0.6912469396240372,
YP2020_Intensity P10_R2_mult_log2,,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,,
NJH2025_Sub1_MICT_Pre,,,,
KBE2022_Log2_Ex_39_T,,,,
FSO2013_Ratio H/M normalized Rep3___2,,,,
RM2024_Intensity D6-2,,,,
EP2017_Untreated R#1 log2 ratio,,0.5010756818532462,0.5613771300254121,
RKK2015_SC-514/basal,,,,
RM2024_Intensity D6-1___3,,,,
WZ2023_Pu_010_10min,,,,
NJH2025_Sub9_HIIT_Mid,,,,
SR2019_SKBR3_Biol_repl_4,,,,
HS2024_5_I_T3,,,,
KS2014_Intensity N1,,,,
NJH2024_Sub12_MICT_Post,,,,
TM2022_S2.8h.C,,,,
CR2017_Ratio Replicate 1,,,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,,
JJ2018_Ratio H/M normalized pP3,,,,
AH2018_SILAC_MR_2_C,,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,,
PG2020_Intensity 2h_A,,,,
NJH2024_Sub6_MICT_Mid,,,,
NJH2025_Sub13_HIIT_Post,,,,
AH2018_SILAC_MR_3_X,,,,
JJ2018_Ratio H/M normalized___1,,,,
RCJD2014_15min_2,,,,
AS2011_Ratio H/L_2,,,,
AS2011_Ratio H/L Normalized,,,,
RN2012_H03,0.4280954847870171,0.51120244561695,,
HS2024_5_B_N2,,,,
HS2024_5_I_N1,,,,
HS2024_6_I_N1,,,,
AR2021_KD 48h,,,,
FR2021_Intensity.B,,,,
RB2022_3_PreEndurance,,0.5274722157648019,,
HS2024_5_I_T1,,,,
NJH2024_Sub10_MICT_Pre,,,,
SR2019_LM2_Biol_repl_2,,,,
AST2020_anti-CD3,,0.5195266816786249,,
SR2019_MDAMB231_Biol_repl_1,,,,
RM2024_Intensity D2-3___3,,,,
WZ2023_Pe_005_10min,,,,
KBE2022_Log2_Ex_29_U,,,,
HS2024_7_B_T1,,,,
AH2018_LFQ_M_2_X,,,,
AH2018_LFQ_IT_4_N,,,,
CK2022_15 200-1,,,,
RM2024_Intensity D4-1___2,,,,
JJ2018_Ratio H/M normalized,,,,
JJ2018_Ratio M/L normalized pP3___1,,,,
KBE2022_Log2_Ex_34_T,,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,,
LY2019_P2+,,,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,,
CK2022_2 200-1,,,,
AS2011_Ratio H/L Protein RNAi_2,,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,,
WZ2023_Su_010_30min,,,,
RN2012_H01,0.44566851049648054,0.5270298773196095,,
KTGR2014_Ratio-Rapa 2 mins,,,,
EJN2021_2_Rest_Basal,,,0.6877153296116391,
KS2014_Intensity pY_E5_3,,,,
MM2018_Ratio H/L replicate 3,,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.507161119479227,0.6096146562514347,
HS2024_8_B_T3,,,,
YA2020_Reporter_intensity_Cancer_No.3,,,,
KBE2022_Log2_Ex_44_U,,,,
WZ2023_Pe_010_20min,,,,
KS2014_Intensity pY_C6,,,,
AS2011_Ratio H/L Normalized_3,,,,
RCJD2014_15min_mean,,,,
RB2022_3_PreStrength,,0.5256128482516161,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.539427947057455,,
RCJD2014_10min_mean,,,,
KS2014_Intensity C1,,,,
FSO2013_Ratio H/M normalized Rep3___1,,0.520089245789001,,
AH2018_SILAC_M_3_C,,,,
RKK2015_TNF-α+IKKb/TNF-α,,,,
RM2024_Intensity D0-3___2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,,
AH2018_SILAC_M_2_C,,,,
AH2018_SILAC_M_2_X,,,,
KTGR2014_Ratio-Rapa 15 mins,,,,
RM2024_Intensity D4-2___1,,,,
KBE2022_Log2_Ex_15_T,,,,
VOI2024_0.1uM 24 h_1 di,,,,
WZ2023_Su_010_10min,,,,
PG2020_Intensity 6h_C,,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,,
JJ2018_Ratio M/L normalized pP1___1,,,,
AH2018_LFQ_M_3_N,,,,
VOI2024_0.1uM 24 h_2 mono,,,,
AH2018_TMTMS2_3_C,,,,
CK2022_15 16-1,,,,
CK2022_3 16-1,,,,
LY2019_P4-,,,,
FSO2013_Ratio H/L normalized Rep3___2,,,,
KS2014_Intensity pY_PV2,,,,
HS2024_3_I_N2,,,,
GF2025_P8_Adh,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,,
GF2025_P5_Sph,,,,
CK2022_10 16-1,,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,,
VOI2024_0.1uM 2 h_2 di,,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5258605032552208,,
NJH2024_Sub2_HIIT_Mid,,,,
AMK2021_45I_p3,,,,
NJH2024_Sub13_HIIT_Mid,,,,
DB2022_LFQ intensity R1.2,,,,
DB2022_Intensity R1,,,,
NJH2024_Sub12_MICT_Mid,,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,,
UK2020_HCM_4,,,,
SAS2015_AZD/DMSO_Exp2,,,,
IMM2018_normalised rep. int. CDK5L-1,,,,
DB2022_LFQ intensity L2.2,,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,,
EP2017_Mitotic R#1 log2 ratio,,0.5095463978904937,0.5896895185422444,
EJN2021_2_Ex_Basal,,,0.6848592614895533,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,,
KTGR2014_Ratio-Rapa 30 mins,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,,
CF2017_FTE 16,,,0.6021928657446637,
AR2021_L41 10 μM,,,,
CF2017_EOC 2,,,0.661687677432917,
RB2022_6_PostEndurance,,0.5124660434523242,,
AH2018_SILAC_1_N,,,,
NJH2024_Sub10_HIIT_Pre,,,,
AS2011_Ratio H/L Inhi_1_2,,,,
UK2020_HCM_6,,,,
RB2022_7_PreSprint,,0.5298540281929371,,
NJH2024_Sub2_MICT_Pre,,,,
HS2024_3_PD_T2,,,,
CK2022_6 16-1,,,,
ZX2022_CB treated Replicate 1,0.43455412559695944,0.5272990345975501,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,,
TM2022_mock.12h.C,,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,,
HH2022_Reporter intensity 0,,,,
RM2024_Intensity D2-2___2,,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,,
RB2022_1_PreStrength,,0.5289662688432097,,
JJ2018_Ratio H/M normalized pP2___2,,,,
AH2018_TMTMS2_2_X,,,,
AR2021_L41 1 μM,,,,
JJ2018_Ratio H/M normalized pP1___2,,,,
AH2018_TMTMS2_1_N,,,,
NJH2025_Sub10_MICT_Pre,,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,,
ZX2022_Control Replicate 3,0.43572029285926417,0.5288756935976971,,
KS2014_Intensity C4,,,,
AS2011_Ratio H/L Inhi_2,,,,
KBE2022_Log2_Ex_18_T,,,,
NJH2025_Sub9_MICT_Pre,,,,
RCJD2014_20min_1,,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,,
FSO2013_Ratio M/L normalized Rep2___3,0.410017222940849,0.5017504655263961,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,,
SR2019_MCF10A_Biol_repl_3,,,,
HS2024_7_B_T2,,,,
SAS2015_PLX/DMSO_Exp3,,,,
AMK2021_Ctrl_p5,,,,
NJH2025_Sub2_HIIT_Mid,,,,
AH2018_LFQ_M_3_C,,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,,
YA2020_Reporter_intensity_Cancer_No.2,,,,
FSO2013_Ratio H/M normalized Rep2___3,,,,
RB2022_8_PreSprint,,0.5251857130666743,,
AH2018_SILAC_IT_3_C,,,,
WZ2023_Pu_025_10min,,,,
RM2024_Intensity D2-2___3,,,,
AS2011_Ratio H/L_1,,,,
RCJD2014_10min_3,,,,
FSO2013_Ratio M/L normalized Rep3___1,0.44371820070704693,0.5469920920232737,,
SR2019_JIMT1_Biol_repl_4,,,,
YP2020_Intensity C10_R2_mult_log2,,,,
ZCP2016_Ratio H/L Rep 2,,,,
CF2017_EOC 4,,,0.6836375927643402,
JJ2018_Ratio H/L normalized pP1___1,,,,
WZ2023_Pe_010_30min,,,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,,
AH2018_LFQ_IT_3_N,,,,
KS2014_Intensity C6,,,,
ZQ2022_N3,,,,
HW2015_Ratio H/L normalized Exp1,,,,
CK2022_12 40-1,,,,
NJH2024_Sub7_MICT_Pre,,,,
ZX2022_Control Replicate 1,0.4420962027266095,0.5308625117097714,,
JJ2018_Ratio H/M normalized pP1,,,,
CK2022_16 40-1,,,,
AH2018_SILAC_IT_2_C,,,,
CK2022_5 40-1,,,,
AH2018_LFQ_3_X,,,,
UK2020_UA_3,,,,
LY2019_P7-,,,,
GF2025_P5_Adh,,,,
RB2022_1_PostStrength,,0.5207999621365628,,
JAW2011_Ratio H/L LS1b,,,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5331750218118148,,
SR2019_HCC1954_Biol_repl_3,,,,
CR2017_Ratio Replicate 2.2,,,,
VOI2024_0.1uM 2 h_1 mono,,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,0.5229908068644962,,
CK2022_11 16-1,,,,
ZQ2022_C1,,,,
CR2017_Ratio Replicate 2.1,,,,
PG2020_Intensity CT_B,,,,
JJ2018_Ratio M/L normalized___2,,,,
AH2018_SILAC_MR_1_N,,,,
KS2014_Intensity pY_E5_1,,,,
JW2021_Before_3,,0.5156109132273018,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,0.5239229413570937,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,,
FS2019_db/db1,,,,
NJH2025_Sub9_HIIT_Pre,,,,
JAW2011_Ratio H/L_1,,,,
RCJD2014_20min_3,,,,
AH2018_LFQ_3_C,,,,
JJ2018_Ratio M/L normalized pP3___2,,,,
AMK2021_45I_p1,,,,
NJH2025_Sub8_HIIT_Post,,,,
AH2018_LFQ_M_3_X,,,,
YA2020_Reporter_intensity_Cancer_No.4,,,,
KS2014_Intensity pY_E5_2,,,,
FSO2013_Ratio H/L normalized Rep1___3,,,,
GF2025_P4_Sph,,,,
RB2022_2_PreEndurance,,0.5297071655235615,,
JW2021_Before_1,,0.5172855580898105,,
KBE2022_Log2_Ex_25_T,,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,,
JJ2018_Ratio M/L normalized___1,,,,
FR2021_Intensity.H,,,,
CK2022_14 16-1,,,,
AST2020_anti-CD3+PDL2,,0.5188783462877059,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,,
KBE2022_Log2_Ex_19_T,,,,
KS2014_Intensity pY_N1,,,,
RB2022_1_RecoveryEndurance,,0.5245554000098226,,
FSO2013_Ratio H/M normalized Rep1___2,,,,
HS2024_8_I_T1,,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,0.5227282900037525,,
EP2017_Mitotic R#2 log2 ratio,,0.5087653824572032,0.6039535470567374,
AH2018_TMTMS2_1_X,,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,,
ZCP2016_Ratio H/L Rep 3,,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,,
SR2019_MCF10A_Biol_repl_1,,,,
NJH2025_Sub8_MICT_Mid,,,,
EJN2021_5_Ex_Ins,,,0.6855314869542429,
HS2024_6_I_N2,,,,
HH2022_Reporter intensity 4,,,,
RBK2021_1326T Late,,,,
TM2022_mock.12h.B,,,,
NJH2024_Sub12_MICT_Pre,,,,
RCJD2014_15min_3,,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,,
LG2023_Control-3_intensity,,,,
JJ2018_Ratio H/L normalized pP3___2,,,,
CF2017_FTE 15,,0.5104884562671623,0.6789740017135789,
HS2024_4_I_T3,,,,
AH2018_SILAC_1_X,,,,
PG2020_Intensity 10h_B,,,,
AH2018_TMTMS3_1_X,,,,
CF2017_FTE 14,,0.5122595717838468,0.5546462367992676,
NJH2024_Sub13_HIIT_Post,,,,
RM2024_Intensity D6-3___3,,,,
NJH2025_Sub7_HIIT_Pre,,,,
RBK2021_1259T Early,,,,
RKK2015_IKK+TNF-α/IKKb,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,,
PG2020_Intensity 6h_A,,,,
SR2019_HCC1419_Biol_repl_3,,,,
KBE2022_Log2_Ex_14_T,,,,
EP2017_Untreated R#2 normalized log2 ratio,,0.5340120660743523,0.5761265738262632,
RM2024_Intensity D0-2___1,,,,
DB2022_Intensity L1,,,,
LY2019_P5+,,,,
HS2024_5_I_N2,,,,
SAS2015_PLX/AZD_Exp3,,,,
EP2017_Pervanadate R#2 log2 ratio,,0.5099324529867972,0.587783444213193,
AS2011_Ratio H/L Normalized RNAi_2_1,,,,
